Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants
about
Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiationSigma receptors: potential targets for a new class of antidepressant drugThe sigma receptor: evolution of the concept in neuropsychopharmacologyThe sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinkingConversion of psychological stress into cellular stress response: roles of the sigma-1 receptor in the processNovel sigma (sigma) receptor agonists produce antidepressant-like effects in micePotentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptorsPotentiation of nerve growth factor-induced neurite outgrowth by fluvoxamine: role of sigma-1 receptors, IP3 receptors and cellular signaling pathways.Sigma-1 receptor chaperones in neurodegenerative and psychiatric disordersFluvoxamine alleviates ER stress via induction of Sigma-1 receptorIdentification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site.Dehydroepiandrosterone and allopregnanolone protect sympathoadrenal medulla cells against apoptosis via antiapoptotic Bcl-2 proteinsAn update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand.Cholesterol at the endoplasmic reticulum: roles of the sigma-1 receptor chaperone and implications thereof in human diseases.A Role for Sigma Receptors in Stimulant Self Administration and Addiction.The sigma1 receptor interacts with N-alkyl amines and endogenous sphingolipids.Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamineTranscription Factor Brn-3b Overexpression Enhances Neurite Outgrowth in PC12 Cells Under Condition of Hypoxia.Fluvoxamine attenuated endoplasmic reticulum stress-induced leptin resistanceThe SSRI citalopram affects fetal thalamic axon responsiveness to netrin-1 in vitro independently of SERT antagonism.Expression of a truncated form of the endoplasmic reticulum chaperone protein, σ1 receptor, promotes mitochondrial energy depletion and apoptosis.Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance.A role for sigma receptors in stimulant self-administration and addiction.Myristic acid hitchhiking on sigma-1 receptor to fend off neurodegeneration.Insights into the Sigma-1 receptor chaperone's cellular functions: a microarray report.Sigma receptors [σRs]: biology in normal and diseased statesCM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain.Dose-response features of neuroprotective agents: an integrative summary.Enhancing and regulating neurite outgrowth.Sigma-1 receptor chaperones regulate the secretion of brain-derived neurotrophic factor.Pharmacology and therapeutic potential of sigma(1) receptor ligands.sigma-1 receptors in major depression and anxiety.Sigma-1 Receptors and Neurodegenerative Diseases: Towards a Hypothesis of Sigma-1 Receptors as Amplifiers of Neurodegeneration and Neuroprotection.Fluvoxamine may prevent onset of psychosis: a case report of a patient at ultra-high risk of psychotic disorder.The Differentiation of Skin Mesenchymal Stem Cells Towards a Schwann Cell Phenotype: Impact of Sigma-1 Receptor Activation.Role of σ1 Receptors in Learning and Memory and Alzheimer's Disease-Type Dementia.Development of easy-to-use reverse-phase liquid chromatographic methods for determining PRE-084, RC-33 and RC-34 in biological matrices. The first step for in vivo analysis of sigma1 receptor agonists.Studies on the enantiomers of RC-33 as neuroprotective agents: isolation, configurational assignment, and preliminary biological profile.Chemical, pharmacological, and in vitro metabolic stability studies on enantiomerically pure RC-33 compounds: promising neuroprotective agents acting as σ₁ receptor agonists.Are sigma receptor modulators a weapon against multiple sclerosis disease?
P2860
Q24563759-5523C6EF-5BD3-4DFA-8216-229DEFA9C5C4Q24567770-4E22639E-CBDE-474C-B182-2E0F6A1983D0Q24651621-828E8C05-89EB-4A7E-A0CA-931444BD916AQ24658287-5825BDD4-7101-4944-9B4C-FDFC9199420FQ27023681-E04F98A7-F1C4-417D-91F8-5D46D4026C14Q28294148-064AFA66-C786-4AFB-BDAF-313B358C9637Q28729237-6B905C69-1936-417B-8784-A545A067A605Q33348563-F19D1609-3991-49DC-92DE-B8F9BD1060E0Q33920251-CB84337B-4561-4BD4-8474-C0F50B6B298FQ34007801-2CBEF1FB-3D99-488A-84C3-E7FCB6E452D3Q34197697-73CEB4C0-290F-40E0-A815-6C2A5D5F150CQ34332681-1A998824-573B-4B5F-BA29-A2D89F75F124Q34655500-77BAB2D8-A4F5-4B8B-8CD6-E68280E44186Q35163209-325D96F0-68A2-44EB-BB4B-DAF5ED5CA9E1Q35197016-A87C24EB-0D6A-43E0-B39D-78B70F5F08C3Q35356324-989799F1-F9AA-49B9-ACEB-84BD852810D4Q35793098-9C279FDB-61AC-47A0-A9B7-7F4FAA480B95Q35858681-C02F5386-DE83-4FC2-BF52-98AC01368FF3Q35971241-A0778FE5-5458-4586-8B7D-39C2CC850CB6Q36035922-6A37DB39-E014-4655-8BD1-BC1091E62985Q36078713-9FC0C552-C6B4-4F41-9B5E-1659367C81FFQ36315198-948E3700-19FC-4042-8D32-37527B74CE9AQ36655919-F24A656E-2EE2-47BF-B68D-6EE6214AD34BQ36786588-87DAA7CD-86C4-474B-A096-90020AE54E67Q36995785-6D41956D-61BD-4812-99B3-056551504A47Q37000551-84A15631-64C8-4DCF-B018-598C30937C08Q37052590-9D54D16B-A6DC-4C31-A97C-C2AB930E382FQ37146134-EE2981D1-BBC7-476E-92B2-F620DEF26E0DQ37146142-9162A7C8-8739-401E-9FAA-2831C0472D18Q37300447-C0BA072D-9DEE-415A-9CDC-12A894C409B8Q37545379-E88E1E2A-C9BB-4291-AF32-173DDBC8BA74Q37546082-9789D75C-9C6E-4EBE-B447-AB89552DECD6Q38743350-9C169305-0DA7-4AC0-9969-DA1289833FF3Q38766222-993E8412-B967-45D7-A419-852D17A17E64Q38813308-FDA9C89B-0FCB-49F7-A834-8671AF08CFE5Q38896662-CA685C0C-D0ED-43B6-8EB1-D3F82E62ABA7Q38955427-D59C22AA-EE88-4F76-86F2-BAAF5B56D3F1Q43695245-8F41F040-F72C-4911-A66F-8E4730A43E30Q46797036-E9ECA546-88D9-4268-91CF-6A3FBF0C6908Q47596098-0CC79BD0-84E3-4C92-9758-D77D2EAE1CA4
P2860
Nerve growth factor-induced neurite sprouting in PC12 cells involves sigma-1 receptors: implications for antidepressants
description
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Dezember 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/12/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/12/01)
@nl
наукова стаття, опублікована в грудні 2002
@uk
مقالة علمية (نشرت في ديسمبر 2002)
@ar
name
Nerve growth factor-induced ne ...... plications for antidepressants
@ast
Nerve growth factor-induced ne ...... plications for antidepressants
@en
Nerve growth factor-induced ne ...... plications for antidepressants
@nl
type
label
Nerve growth factor-induced ne ...... plications for antidepressants
@ast
Nerve growth factor-induced ne ...... plications for antidepressants
@en
Nerve growth factor-induced ne ...... plications for antidepressants
@nl
prefLabel
Nerve growth factor-induced ne ...... plications for antidepressants
@ast
Nerve growth factor-induced ne ...... plications for antidepressants
@en
Nerve growth factor-induced ne ...... plications for antidepressants
@nl
P2093
P356
P1476
Nerve growth factor-induced ne ...... plications for antidepressants
@en
P2093
Minoru Takebayashi
Teruo Hayashi
Tsung-Ping Su
P304
P356
10.1124/JPET.102.041970
P407
P577
2002-12-01T00:00:00Z